Alternative bacteriophage life cycles: the carrier state of Campylobacter jejuni
- PMID: 24671947
- PMCID: PMC3971406
- DOI: 10.1098/rsob.130200
Alternative bacteriophage life cycles: the carrier state of Campylobacter jejuni
Abstract
Members of the genus Campylobacter are frequently responsible for human enteric disease, often through consumption of contaminated poultry products. Bacteriophages are viruses that have the potential to control pathogenic bacteria, but understanding their complex life cycles is key to their successful exploitation. Treatment of Campylobacter jejuni biofilms with bacteriophages led to the discovery that phages had established a relationship with their hosts typical of the carrier state life cycle (CSLC), where bacteria and bacteriophages remain associated in equilibrium. Significant phenotypic changes include improved aerotolerance under nutrient-limited conditions that would confer an advantage to survive in extra-intestinal environments, but a lack in motility eliminated their ability to colonize chickens. Under these circumstances, phages can remain associated with a compatible host and continue to produce free virions to prospect for new hosts. Moreover, we demonstrate that CSLC host bacteria can act as expendable vehicles for the delivery of bacteriophages to new host bacteria within pre-colonized chickens. The CSLC represents an important phase in the ecology of Campylobacter bacteriophage.
Keywords: Campylobacter; Campylobacter jejuni; bacteriophages; carrier state life cycle; phage therapy.
Figures
Similar articles
-
Host adaption to the bacteriophage carrier state of Campylobacter jejuni.Res Microbiol. 2015 Jul-Aug;166(6):504-15. doi: 10.1016/j.resmic.2015.05.003. Epub 2015 May 22. Res Microbiol. 2015. PMID: 26004283 Free PMC article.
-
The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens.BMC Microbiol. 2010 Sep 1;10:232. doi: 10.1186/1471-2180-10-232. BMC Microbiol. 2010. PMID: 20809975 Free PMC article.
-
Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens.Appl Environ Microbiol. 2005 Nov;71(11):6554-63. doi: 10.1128/AEM.71.11.6554-6563.2005. Appl Environ Microbiol. 2005. PMID: 16269681 Free PMC article.
-
Campylobacter bacteriophages and bacteriophage therapy.J Appl Microbiol. 2011 Aug;111(2):255-65. doi: 10.1111/j.1365-2672.2011.05012.x. Epub 2011 Apr 20. J Appl Microbiol. 2011. PMID: 21447013 Review.
-
The Bacteriophage Carrier State of Campylobacter jejuni Features Changes in Host Non-coding RNAs and the Acquisition of New Host-derived CRISPR Spacer Sequences.Front Microbiol. 2016 Mar 23;7:355. doi: 10.3389/fmicb.2016.00355. eCollection 2016. Front Microbiol. 2016. PMID: 27047470 Free PMC article. Review.
Cited by
-
Aerotolerancy of Campylobacter spp.: A Comprehensive Review.Pathogens. 2024 Sep 28;13(10):842. doi: 10.3390/pathogens13100842. Pathogens. 2024. PMID: 39452714 Free PMC article. Review.
-
Isolation and characterisation of ΦcrAss002, a crAss-like phage from the human gut that infects Bacteroides xylanisolvens.Microbiome. 2021 Apr 12;9(1):89. doi: 10.1186/s40168-021-01036-7. Microbiome. 2021. PMID: 33845877 Free PMC article.
-
The coordination of anti-phage immunity mechanisms in bacterial cells.Nat Commun. 2022 Dec 1;13(1):7412. doi: 10.1038/s41467-022-35203-7. Nat Commun. 2022. PMID: 36456580 Free PMC article.
-
Phage Biocontrol of Campylobacter jejuni in Chickens Does Not Produce Collateral Effects on the Gut Microbiota.Front Microbiol. 2019 Mar 12;10:476. doi: 10.3389/fmicb.2019.00476. eCollection 2019. Front Microbiol. 2019. PMID: 30930877 Free PMC article.
-
Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses.J Med Microbiol. 2020 Feb;69(2):176-194. doi: 10.1099/jmm.0.001141. Epub 2020 Jan 24. J Med Microbiol. 2020. PMID: 31976857 Free PMC article. Review.
References
-
- Newell DG, et al. 2011. Biosecurity-based interventions and strategies to reduce Campylobacter spp. on poultry farms. Appl. Environ. Microbiol. 77, 8605–8614. (doi:10.1128/AEM.01090-10) - DOI - PMC - PubMed
-
- Connerton PL, Timms AR, Connerton IF. 2011. Campylobacter bacteriophages and bacteriophage therapy. J. Appl. Microbiol. 111, 255–265. (doi:10.1111/j.1365-2672.2011.05012.x) - DOI - PubMed
-
- Adams MH. 1959. Bacteriophage. New York, NY: Interscience.
-
- Abedon S. 2009. Disambiguating bacteriophage pseudolysogeny: an historical analysis of lysogeny, pseudolysogeny and the phage carrier state. In Contemporary trends in bacteriophage research (ed. Adams HT.), pp. 285–307. New York, NY: Nova Science Publishers.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
